Results 41 to 50 of about 851,380 (306)

Glycerol for Acute Stroke [PDF]

Stroke, 2000
Brain oedema is a major cause of early death after stroke. A 10% solution of glycerol is a hyperosmolar agent that is claimed to reduce brain oedema.To determine whether I.V. glycerol treatment in acute stroke, either ischaemic or haemorrhagic, influences death rates and functional outcome in the short or long term and whether the treatment is safe.The
Righetti, Enrico, Celani, Maria Grazia, Cantisani, Teresa Anna, Sterzi, Roberto, Boysen, Gudrun, Ricci, Stefano   +5 more
openaire   +5 more sources

Data science of stroke imaging and enlightenment of the penumbra. [PDF]

, 2015
Imaging protocols of acute ischemic stroke continue to hold significant uncertainties regarding patient selection for reperfusion therapy with thrombolysis and mechanical thrombectomy.
Liebeskind, David S, Nour, May, Scalzo, Fabien   +2 more
core   +5 more sources

Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke?: an analysis of placebo-treated patients from prospective acute stroke trials [PDF]

, 2008
<p><b>Background and Purpose:</b> The influence of stroke lateralization on functional and cardiovascular outcome after stroke is not well established.
Fink, J.N., Frampton, C.M., Lees, K.R., Lyden, P.   +3 more
core   +1 more source

Acute Stroke [PDF]

Hypertension, 2010
Not much progress has occurred in guidelines to treat blood pressure (BP) during acute stroke since Sir George Pickering wrote in 1968 about cerebral hemorrhage: “Probably diastolic pressures over 110 are worth reducing to 90 mm Hg. This is a guess, and theoretical arguments could be urged against, or for, different figures,” and about ischemic stroke:
Fernando Elijovich, Cheryl L. Laffer
  +4 more sources

Naftidrofuryl for Acute Stroke [PDF]

Stroke, 2005
Stroke is the third most common cause of death and the most common cause of disability in the western world. The development of drugs to limit the effects of brain damage caused by stroke continues but no routine effective treatment has yet been identified.
J, Leonardi-Bee, T, Steiner, F, Bath-Hextall   +2 more
openaire   +2 more sources

Hyperemia detection on arterial spin labeling is associated with final infarct volume in stroke post-endovascular therapy

Journal of Stroke and Cerebrovascular Diseases
Background and Purpose: Patients with acute ischemic stroke (AIS) treated with endovascular therapy (EVT) may develop hyperemia due to loss of relative cerebral blood flow (rCBF) autoregulation.
Carolyn A. Lomahan, BS, Marie Luby, PhD, Georgios Kalarakis, MD, PhD, Amie W. Hsia, MD, John K. Lynch, DO, MPH, Karan P. Nathani, MD, Sana Somani, MD, Leila C. Thomas, BSN, MPH, Fabian Arnberg-Sandor, MD, PhD, Lawrence L. Latour, PhD   +9 more
doaj   +1 more source

Decrease of thyroid function after ischemic stroke is related to stroke severity

Thyroid Research, 2023
Background Thyroid hormones are of fundamental importance for brain function. While low triiodothyronine levels during acute ischemic stroke (AIS) are associated with worse clinical outcomes, dynamics of thyroid function after AIS remains unknown.
Evgeny Sidorov, Aruna Paul, Chao Xu, Claire Delpirou Nouh, Allshine Chen, Albina Gosmanova, Niyaz Gosmanov, David Lee Gordon, Irina Baranskaya, Juliane Chainakul, Robert Hamilton, Alexander Mdzinarishvili   +11 more
doaj   +1 more source

Acute Stroke Care in Mexico City: The Hospital Phase of a Stroke Surveillance Study

Brain Sciences, 2022
Background: Acute stroke care has greatly improved in recent decades. However, the increasing stroke mortality in low-to-middle income countries suggests that progress has not been reached completely by these populations.
Emmanuel Aguilar-Salas, Guadalupe Rodríguez-Aquino, Katya García-Domínguez, Catalina Garfias-Guzmán, Erika Hernández-Camarillo, Nayeli Oropeza-Bustos, Rubí Arguelles-Castro, Ameyalli Mitre-Salazar, Gloria García-Torres, Marco Reynoso-Marenco, Eduardo Morales-Andrade, Luis Gervacio-Blanco, Víctor García-López, Gabriel Valiente-Herves, Manuel Martínez-Marino, Fernando Flores-Silva, Erwin Chiquete, Carlos Cantú-Brito   +17 more
doaj   +1 more source

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up? [PDF]

, 2020
Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic medication for acute ischemic stroke. However, multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as ...
Ataya, Ramsey, Brea, Isabel, Zitek, Tony
core  

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke [PDF]

, 2016
BACKGROUND Previous studies conducted between 1997 and 2003 estimated that the risk of stroke or an acute coronary syndrome was 12 to 20% during the first 3 months after a transient ischemic attack (TIA) or minor stroke.
Albers, Gregory W., Amarenco, Pierre, Bornstein, Natan M., Canhão, Patrícia, Caplan, Louis R., Donnan, Geoffrey A., Ferro, José M., Hennerici, Michael G., Labreuche, Julien, Lavallée, Philippa C., Molina, Carlos, org Steering Committee, T. I. A. r. e. g. i. s. t. r. y., Rothwell, Peter M., Sissani, Leila, Steg, Philippe Gabriel, Toni, Danilo, Touboul, Pierre Jean, Uchiyama, Shinichiro, Vicaut, Éric, Wong, Lawrence K. S., Školoudík, David   +20 more
core   +2 more sources